SCHEMBL19081885

SCHEMBL19081885

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5cc6c7ccccc7sc6c6c5oc5ccc7ccccc7c56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.36
PAX8 Q06710 2/20 0.36
CYP1A1 P04798 2/20 0.36
CYP1A2 P05177 1/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
AHR P35869 1/20 0.36
PGR P06401 1/20 0.34
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
ESR2 Q92731 2/20 0.32
KDM4E B2RXH2 2/20 0.32
ESR1 P03372 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081774 0.92 ABCG2 (0.40) ABCG2PAX8CYP1A1CYP1A2FYN
SCHEMBL19082200 0.84 TNKS (0.35) CYP1A1TNKSTNKS2KMT2AESR2
SCHEMBL19081875 0.83 ABCG2 (0.39) ABCG2PAX8CYP1A1CYP1A2FYN
SCHEMBL17945505 0.82 TNKS (0.39) TNKSTNKS2ESR2ESR1MAPT
SCHEMBL19081870 0.82 ABCG2 (0.38) ABCG2PAX8CYP1A1CYP1A2FYN
SCHEMBL19081826 0.82 CYP1A1 (0.38) ABCG2CYP1A1CYP1A2TNKSTNKS2
SCHEMBL19081486 0.81 ABCG2 (0.40) ABCG2PAX8CYP1A1CYP1A2FYN
SCHEMBL19081880 0.81 CYP1A1 (0.38) ABCG2PAX8CYP1A1CYP1A2FYN
SCHEMBL17944810 0.81 S1PR5 (0.34) CYP1A1CYP1A2TNKSTNKS2ESR2
SCHEMBL17944279 0.81 TNKS (0.41) CYP1A1TNKSTNKS2ESR2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885PAX8 2336/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885PAX8 2336/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.